Abdominal obesity and androgenetic alopecia in male patients of the dermatological profile
Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2018;17(5):142-147.
The prevention of cardiovascular diseases is one of the major directions of medicine. Abdominal obesity is the main sign in the diagnosis of metabolic syndrome, complications of which are cardiovascular diseases. Depending on the population, onset and clinical manifestations androgenetic alopecia can be associated with metabolic syndrome, insulin resistance, hyperlipidemia. The aim of this study was to investigate the occurrence rate of abdominal obesity and androgenetic alopecia in dermatological male patients.
Material and methods. One hundred male patients at the age of 30 years and older who had different skin pathologies were observed. Clinical, anthropometric methods of investigation were used.
Results. All examined patients were able-bodied (mean age – 50,9±11,6 years). Abdominal obesity was diagnosed in 62 (62%) of patients, 44 (44%) of them had androgenetic alopecia with the predominance of its vertex type of mild and moderate severity. Thirty (68,1%) male patients with androgenetic alopecia suffered from abdominal obesity, this occurred more frequently than in patients without androgenetic alopecia – 32 (57,1%) persons. Seventeen (40,4%) patients with the vertex type of androgenetic alopecia had arterial hypertension of various severity degree, this occurred more often than in patients without androgenetic alopecia – 14 (25%) subjects. The combination of androgenetic alopecia, arterial hypertension and abdominal obesity was observed in 13 (29,5%) male patients. The combination of androgenetic alopecia, arterial hypertension and psoriasis was observed in 12 male patients (27,2%). The combination of androgenetic alopecia, arterial hypertension, abdominal obesity and psoriasis was observed in 11 male patients (25%).
Conclusions. Further studies are needed for drawing definitive conclusions concerning the combination of these diseases and possible pathogenetic connection between them.
Key words: androgenetic alopecia, abdominal obesity, psoriasis.
1. Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen GB, Nordestgaard BG, Tybjarg-Hansen A. Visible Age-Related Signs and Risk of Ischemic Heart Disease in the General Population A Prospective Cohort Study. Circulation. 2014 Mar;129(9):990-8. doi: http://dx.doi.org/10.1161/CIRCULATIONAHA.113.001696
2. Lebwohl M, Lebwohl E, Bercovitch L. Prominent mental (chin) crease: A new sign of pseudoxanthoma elasticum. J Am Acad Dermatol. 2003 Apr;48(4):620-2. doi: http://dx.doi.org/10.1067/mjd.2003.195
3. Sivagnanam G. Baldness, a new marker for coronary heart disease risk. J Pharmacol Pharmacother. 2013;4(3):223-4.
4. Yamada T, Hara K, Umematsu H, Kadowaki T. Male pattern baldness and its association with coronary heart disease: a meta-analysis. BMJ Open. 2013;3(4):e002537. doi: http://dx.doi.org/10.1136/bmjopen-2012-002537
5. Su LH, Chen TH. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. Br J Dermatol. 2010 Aug;163(2):371-7. doi: http://dx.doi.org/10.1111/j.1365-2133.2010.09816.x
6. Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: Skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007 Jun;56(6):901-16. doi: http://dx.doi.org/10.1016/j.jaad.2006.12.004
7. Mamedov MN, Chepurina NA; Oganov RG, red. Total cardiovascular risk: from theory to practice. Moscow, RF; 2007. 40 р. (In Russ.)
8. International Diabetes Federation (IDF): consensus on metabolic syndrome criteria. Ozhirenie Metabolizm. 2005;(3):47-9. (In Russ.)
9. González-González JG, Mancillas-Adame LG, Fernández-Reyes M, Gómez-Flores M, Lavalle-González FJ, Ocampo-Candiani J, et al. Androgenetic alopecia and insulin resistance in young men. Clin Endocrinol (Oxf). 2009 Oct;71(4):494-9. doi: http://dx.doi.org/10.1111/j.1365-2265.2008.03508.x
10. Matilainen V, Koskela P, Keinänen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet. 2000 Sep;356(9236):1165-6. doi: http://dx.doi.org/10.1016/S0140-6736(00)02763-X
11. Zhuk TV, Yavorskaya SD, Vostrikov VV. Obesity, reproduction and oxidative stress. Ozhirenie Metabolizm. 2017;14(4):16-22. (In Russ.)
12. Upton JH, Hannen RF, Bahta AW, Farjo N, Farjo B, Philpott MP. Oxidative stress associated senescence in dermal papilla cells of men with androgenetic alopecia. J Invest Dermatol. 2015 May;135(5):1244-52. doi: http://dx.doi.org/10.1038/jid.2015.28
13. Veremeev AV, Bolgarin RN, Petkova MA, Kats N, Nesterenko VG. Stromal-vascular fraction of adipose tissue as an alternative source of cellular material for regenerative medicine. Geny Kletki. 2016;11(1):35-42. (In Russ.)
14. Mancuso P. The role of adipokines in chronic inflammation. Immunotargets Ther. 2016 May;5:47-56. doi: http://dx.doi.org/10.2147/ITT.S73223
15. El-Domyati M, Attia S, Saleh F, Abdel-Wahab H. Androgenetic alopecia in males: a histopathological and ultrastructural study. J Cosmet Dermatol. 2009 Jun;8(2):83-91. doi: http://dx.doi.org/10.1111/j.1473-2165.2009.00439.x
Information about authors:
Tikhonovskaya I.V. – Candidate of Medical Sciences, associate professor of the Chair of Dermatovenerology, Vitebsk State Order of Peoples’ Friendship Medical University.